Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Latest filing published 20 Aug 2026 for Viridian Therapeutics, Inc.\DE, €89k. Read the official filing
Filing timeline
BuySaleJennifer Tousignant
Insider track record
Disclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Jennifer Tousignant: trading record in brief
This profile gathers the share dealings of Jennifer Tousignant in Viridian Therapeutics, Inc.\DE, where the filings describe the role as senior executive. Between 31 December 2025 and 19 August 2026, the trades on record add up to 6 filings.
Sales make up the whole of the open-market record (3 sales, €361k). The rest of the record consists of 1 share grant and 2 option exercises. 2026 to date brings no purchases and 3 sales.
On 20 August 2026 came the latest disclosure, an open-market sale for €89k in Viridian Therapeutics, Inc.\DE. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jennifer Tousignant
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
4,212 shares@ US$24.50Common StockSEC:0001193125-26-359636:0
10,000 shares@ US$14.41Common StockSEC:0001193125-26-359636:1
10,000 shares@ US$24.50Common StockSEC:0001193125-26-359636:2
1,675 shares@ US$30.190.0019% mcap50.0% of flowCommon StockSEC:0001193125-26-099008:0
5,169 sharesCommon StockSEC:0001193125-26-092074:0
2,272 shares@ US$31.1658.2% of flowCommon StockSEC:0001193125-26-001097:0
6 of 6 declarations
